InSightec’s Exablate Neuro System Awarded Korean Regulatory Approval
Tuesday, December 1, 2015
The Korean Ministry of Food and Drug Safety has approved InSightec’s Exablate Neuro system for the treatment of movement, pain and behavioral disorders.
The noninvasive treatment combines focused ultrasound to lesion the targeted tissue deep in the brain and magnetic resonance imaging to guide the ultrasound waves to the specific target tissue.
It provides an alternative to deep brain stimulation, radiofrequency ablation and radiosurgery, according to the company.